Cargando…
Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in CTLA4 gene: A case report
BACKGROUND: Cytotoxic T Lymphocyte Antigen-4 (CTLA4) deficiency is a genetic defect that causes a common variable immunodeficiency (CVID) clinical phenotype. Several studies have reported an association between CTLA mutations or variants and various autoimmune diseases. Targeted therapy models, whic...
Autores principales: | Musabak, Ugur, Erdoğan, Tuba, Ceylaner, Serdar, Özbek, Emre, Suna, Nuretdin, Özdemir, Binnaz Handan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507547/ https://www.ncbi.nlm.nih.gov/pubmed/37731560 http://dx.doi.org/10.12998/wjcc.v11.i26.6176 |
Ejemplares similares
-
A Case of Common Variable Immunodeficiency with CREBP Gene Mutation without Rubinstein Taybi Syndrome Features
por: Musabak, Ugur, et al.
Publicado: (2022) -
A case of autoimmune enteropathy with CTLA4 haploinsufficiency
por: Miyazaki, Haruka, et al.
Publicado: (2022) -
Abatacept is effective in Chinese patients with LRBA and CTLA4 deficiency
por: Yang, Lu, et al.
Publicado: (2020) -
Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis
por: Sawamura, Masato, et al.
Publicado: (2020) -
Case Report: “Primary Immunodeficiency”—Severe Autoimmune Enteropathy in a Pediatric Heart Transplant Recipient Treated With Abatacept and Alemtuzumab
por: Kalaidina, Elizaveta, et al.
Publicado: (2022)